Net profit of Shree Ganesh Biotech India rose 440.00% to Rs 0.54 crore in the quarter ended March 2024 as against Rs 0.10 crore during the previous quarter ended March 2023. Sales declined 52.63% to Rs 3.78 crore in the quarter ended March 2024 as against Rs 7.98 crore during the previous quarter ended March 2023.
For the full year,net profit declined 69.61% to Rs 0.62 crore in the year ended March 2024 as against Rs 2.04 crore during the previous year ended March 2023. Sales declined 67.53% to Rs 20.28 crore in the year ended March 2024 as against Rs 62.45 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 3.78 | 7.98 | -53 | 20.28 | 62.45 | -68 |
| OPM % | -13.76 | -6.02 | - | -1.04 | 3.46 | - |
| PBDT | 0.54 | 0.10 | 440 | 0.85 | 2.72 | -69 |
| PBT | 0.54 | 0.10 | 440 | 0.85 | 2.72 | -69 |
| NP | 0.54 | 0.10 | 440 | 0.62 | 2.04 | -70 |